NCT00107341: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction |
|
|
| Completed | 2 | 37 | US | bortezomib, carboplatin, paclitaxel | Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI) | Esophageal Cancer | 02/07 | 05/08 | | |
